is based on 10 years of research at Alzheon, and the company believes it is a well-tolerated new treatment for Alzheimer's disease. 5. What other information is available about Alzheon?

Alzheon has a dedicated management team, board of directors, and scientific advisory board. The company also provides information about its pipeline, clinical data, and mechanism of action, as well as news and publications related to its work.

Voyager DB

Deep data on millions of local businesses, with verified decision-makers to reveal.

Contact Research

Hand-built prospect lists from human researchers, delivered in 24 hours.

People Search

Find owners and decision-makers by job title, seniority and department.

Chrome Extension

Coldlytics in your browser - prospect any business as you browse the web.

Integrations

Instantly, Smartlead, lemlist, Clay, HighLevel, plus Claude and ChatGPT over MCP.

Voyager DBDeep data on millions of local businesses, with verified decision-makers to reveal.Contact ResearchHand-built prospect lists from human researchers, delivered in 24 hours.People SearchFind owners and decision-makers by job title, seniority and department.Chrome ExtensionColdlytics in your browser - prospect any business as you browse the web.IntegrationsInstantly, Smartlead, lemlist, Clay, HighLevel, plus Claude and ChatGPT over MCP.

PricingPricing AgenciesAgencies BlogBlog

LoginLogin

Alzheon

Q: What is Alzheon's mission?

Alzheon is committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.

$7.2M revenue • 40 employees • 111 Speen St #306, Framingham, MA, 01701, United States

Last Updated Nov 18, 2025

Own this business? Claim & update this listing →

Company Overview

Company Name

Alzheon

Address

111 Speen St #306, Framingham, MA, 01701, United States

Website

alzheon.com

Phone

(508) 861-7709

Approx. Annual Revenue

$7.2M

Employees

Established

2013

Google Reviews

5.0 (1 review)

About Alzheon

Alzheon is a biopharmaceutical company committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders. The company is headquartered in Framingham, Massachusetts, and its lead candidate, ALZ-801, is currently in phase 3 clinical trials as an oral anti-amyloid treatment with the potential to slow or stop the progression of Alzheimer's disease.

Business Profile

Read from the Alzheon website on Oct 22, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed): 8/10 · Current news and publications; Clear pipeline and careers pages
Footer copyright year: 2026

Alzheon is hiring

Open roles listed on their website as of Oct 22, 2026.

Head of Real-World Evidence
Clinical Data Technology Lead
Vice President, Artificial Intelligence
Vice President, Project Management
Director, Medical Informatics
Director, Process Chemistry

Hiring in: Management, Clinical

View careers page →

Recent changes

What changed on the Alzheon website and Google listing, as detected by Coldlytics on each visit.

Oct 22, 2026
Started advertising open roles
Head of Real-World Evidence, Clinical Data Technology Lead, Vice President, Artificial Intelligence
Oct 21, 2026
Google Ads pixel installed

Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.

Find companies by what just changed →

Biotech & Life Sciences Companies near Framingham, MA

Browse all Biotech & Life Sciences companies in Massachusetts →

Frequently Asked Questions about Alzheon

Advertising Pixels

Google Ad Pixel

Technologies Used

Key Decision Makers

Luke Tolar Director, Business Development

Audrey Rossow Senior Director, Clinical Operations